Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kromax South Asia is a Singapore-based engineering and commercial solutions company with operations spanning manufacturing, healthcare, and personal health. In healthcare, the company operates through Kromax Medical, supplying hospitals and clinicians with medical devices and patient-care technologies focused on pain management, radiofrequency ablation, cooled radiofrequency, endoscopy spine systems, phototherapy, and neuromodulation-related products. The broader group originated from Kromax's Taiwan roots and established its South Asia business in Singapore in 2003, later expanding into Malaysia and Indonesia. Rather than a drug-development biotech, it appears to function primarily as a regional distributor, integrator, and service provider for third-party technologies in Southeast Asia. Its business model centers on sourcing technologies from international partners and supporting implementation, service, and commercialization in local markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kromax South Asia.